Tech Company Financing Transactions
LoneStar Heart Funding Round
LoneStar Heart, operating out of Laguna Hills, secured $20 million from Themes Investment Partners and private investors.
Transaction Overview
Company Name
Announced On
10/10/2012
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Themes Investment Partners (Lead Investor) (Frank Yu)
Proceeds Purpose
LoneStar Heart Inc. today announced the completion of an up to $20 million milestone-based equity financing to support the clinical testing andregulatory clearance of its lead product, Algisyl-LVR, a single-use, self-gelling biopolymerimplanted into the heart's left ventricle during surgery for the treatment of advanced heart failure.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
26051 Merit Cir. 102
Laguna Hills, CA 92653
USA
Laguna Hills, CA 92653
USA
Phone
Website
Email Address
Overview
LoneStar Heart, Inc. is a Texas and California based biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Olav Bergheim
Chief Operating Officer
Frank Ahmann
VP - Regulatory Affairs
Andy Hinson
Browse more venture capital transactions:
Prev: 10/10/2012: Incentive Targeting venture capital transaction
Next: 10/10/2012: IO Data Centers venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs